Experimental cell therapy for advanced tumors shows early promise
NCT ID NCT05868915
First seen Feb 01, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This early-phase study tested a new treatment called HV-101 for people with advanced solid tumors that had come back or spread. The treatment uses a patient's own immune cells (TILs) taken from their tumor, grown in a lab, and then given back to fight the cancer. The study was stopped early after enrolling only one person, so we have very limited information on safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, 430060, China
Conditions
Explore the condition pages connected to this study.